Finance 26 May 2026

AirSculpt Shares Slip as June Investor Test Looms

AirSculpt Shares Slip as June Investor Test Looms

AirSculpt Technologies shares fell 2.9% to $5.38 Friday, trailing small-cap peers ahead of two June investor events where executives aim to defend the company’s outlook. First-quarter revenue was flat at $39.4 million, with net loss narrowing to $2.4 million. The company raised $14.6 million in a share sale this quarter, using most to pay down debt. Investors remain focused on management’s response to weight-loss drug competition.
May 29, 2026
First Financial Bankshares shares move up as trading resumes post-holiday

First Financial Bankshares shares move up as trading resumes post-holiday

First Financial Bankshares shares rose 1.3% to $32.64 Tuesday, with trading volume at 775,663 and a market value near $4.68 billion. The move followed a market holiday and came without new earnings, as investors reacted to April results and the latest rate changes. The company last reported first-quarter profit of $71.54 million and raised its dividend 15.8% for July payout.
May 26, 2026
Plains GP Stock Drops After Holiday Break — What the Move Signals Now

Plains GP Stock Drops After Holiday Break — What the Move Signals Now

Plains GP Holdings LP shares fell 1.7% to $25.51 Tuesday, underperforming the broader market as pipeline stocks slipped after the Memorial Day break. No new company news was posted, with the latest update remaining the May 12 sale of its Canadian NGL business for $3.3 billion. Plains All American Pipeline dropped 2.4%. PAGP traded near the top of its 52-week range.
May 26, 2026
Travelzoo Gains as Shares Tick Higher, Traders Look at the Small Cap

Travelzoo Gains as Shares Tick Higher, Traders Look at the Small Cap

Travelzoo shares rose 0.8% to $10.11 in late Nasdaq trading Tuesday after U.S. markets reopened from the Memorial Day holiday. The company last reported first-quarter revenue of $24.3 million, up 5% year over year, and earnings per share of 23 cents. Operating income slipped to $3.45 million as sales and marketing costs increased. Trading volume reached about 89,600 shares.
May 26, 2026
Senstar Drops After Q1 as Lidar Strategy in Focus

Senstar Drops After Q1 as Lidar Strategy in Focus

Senstar Technologies shares fell 4% to $2.68 Tuesday after reporting a $0.8 million net loss and a 4% revenue decline to $8.1 million in Q1. LiDAR sales quadrupled but higher costs from the Blickfeld acquisition and delays in U.S. government projects weighed on results. Gross margin narrowed to 60%. The company ended March with $10.6 million in cash and no debt.
May 26, 2026
Bank First Shares Fall After $203 Million PSB Deal

Bank First Shares Fall After $203 Million PSB Deal

Bank First Corp shares fell 0.4% to $141.32 after announcing a $203 million all-stock deal to acquire PSB Holdings. The drop trailed a 1.0% gain in the SPDR S&P Regional Banking ETF and stronger moves by other Wisconsin banks. The deal values PSB at about $49.04 a share, below Bank First’s earlier estimate. The acquisition still requires regulatory and shareholder approval.
May 26, 2026
Slide Insurance (SLDE) ticks higher in Florida insurer IPO push

Slide Insurance (SLDE) ticks higher in Florida insurer IPO push

Slide Insurance Holdings shares rose 0.4% to $18.71 Tuesday, lifting its market cap to nearly $2.56 billion. Safepoint set a target valuation of up to $1.16 billion in a planned U.S. IPO, putting focus on Florida property insurers. Slide last reported first-quarter net income up 50.8% at $139.5 million and announced a $100 million buyback.
May 26, 2026
NeuroSense trades close to 90 cents as next $1 Nasdaq threshold comes into view

NeuroSense trades close to 90 cents as next $1 Nasdaq threshold comes into view

NeuroSense Therapeutics shares rose 5 cents to 87 cents Tuesday, staying below Nasdaq’s $1 minimum bid price. The company faces delisting risk, needing its stock to close above $1 and its market value to reach $35 million for 10 days by Sept. 29, 2026. NeuroSense recently raised $600,000 in a private share sale. Its ALS drug candidate, PrimeC, is set for Phase 3 trials after FDA clearance.
May 26, 2026
Indaptus Therapeutics Drops on Cash Runway Worries

Indaptus Therapeutics Drops on Cash Runway Worries

Indaptus Therapeutics shares fell 6.6% to $1.14 Tuesday after the company reported $1.5 million in cash at March 31 and raised “substantial doubt” about its ability to continue operating. The company stopped enrolling patients in its main clinical trial and has no approved therapies or product revenue. Indaptus converted all Series AA and AAA preferred shares into 111 million common shares during the quarter.
May 26, 2026
Pilgrim’s Pride lags as Nasdaq rallies; margin risk in focus

Pilgrim’s Pride lags as Nasdaq rallies; margin risk in focus

Pilgrim’s Pride shares fell 1.2% to $28.13 in early afternoon trading Tuesday, underperforming gains in the broader U.S. market. The drop followed first-quarter results showing net sales up 1.6% but GAAP earnings per share down 65.3%. About 430,000 shares traded, with the company’s market cap near $6.7 billion. Investors remain focused on pressured chicken margins after a quiet holiday weekend.
May 26, 2026
Reading International Stock Remains Near $1 Despite Big Holiday Box Office

Reading International Stock Remains Near $1 Despite Big Holiday Box Office

Reading International Class A shares rose 1 cent to $1.05 Tuesday, with 23,443 shares traded as U.S. markets reopened after Memorial Day. The company reported a first-quarter net loss of $8.1 million, up from $4.8 million a year earlier, and ended March with $5.5 million in cash against $184.6 million in debt. Plans include property sales and refinancing efforts to address liquidity.
May 26, 2026
U.S. Gold Stock Gains as Gold Price Drops

U.S. Gold Stock Gains as Gold Price Drops

U.S. Gold Corp. shares rose 2.2% to $15.82 Tuesday as trading resumed after Memorial Day, with about 65,714 shares changing hands. The move tracked gains in junior gold miners, despite spot gold falling 1.3% to $4,511.23 an ounce. The company’s CK Gold project in Wyoming remains its main focus. U.S. Gold’s next annual meeting is set for Oct. 13, 2026.
May 26, 2026
Standard BioTools shares hold over $1 as Nasdaq deadline nears

Standard BioTools shares hold over $1 as Nasdaq deadline nears

Standard BioTools shares rose 4.4% to $1.075 early Tuesday, trading above Nasdaq’s $1 minimum bid but still short of the required compliance streak. Volume reached about 1.19 million shares. The company reported Q1 revenue of $21.1 million, up 5%, with lower costs but weak instrument demand. Standard BioTools has until Oct. 19 to regain full compliance with Nasdaq rules.
May 26, 2026
Intuit QuickBooks Index flags small-business job losses as U.S. payrolls report nears

Intuit Drops Again With TurboTax AI Questions Back in Focus

Intuit shares fell 3.8% to $307.93 midday Tuesday, underperforming tech peers after Mizuho cut its price target to $500 from $600. The drop followed weak TurboTax results, rising AI competition, and news of a 17% staff cut. Intuit raised its full-year revenue forecast but lowered its TurboTax outlook. The company expects up to $340 million in restructuring charges.
May 26, 2026
Quantumsphere Shares Flat After Holiday Reopen With $300 Million SPAC Deal Ahead

Quantumsphere Shares Flat After Holiday Reopen With $300 Million SPAC Deal Ahead

Quantumsphere Acquisition Corp. shares showed zero volume by midday Tuesday, quoted at $10.19 on Robinhood. QUMSU units last traded flat at $10.34. The $300 million SACH merger remains pending, awaiting approvals and minimum cash after redemptions. Nasdaq rose over 1% as tech stocks rallied, but Quantumsphere shares did not move.
May 26, 2026
1 8 9 10 11 12 211

Stock Market Today

  • Universal Music Group Rejects Bill Ackman's $64.3 Billion Takeover Bid
    May 29, 2026, 4:36 PM EDT. Universal Music Group, the global entertainment leader, has officially rejected a $64.3 billion takeover offer from billionaire Bill Ackman's investment firm, Pershing Square. The company stated the bid significantly undervalues the business, citing concerns for shareholders, artists, and fans. Universal operates renowned labels such as EMI and Island Records, and iconic Abbey Road Studios. Pershing Square, which holds a stake in Universal, had aimed to list the company on the U.S. stock exchange and revitalize its share price, which Ackman claimed was suppressed due to unrelated financial issues. Bolloré Group, another major stakeholder, opposed the bid. Universal pledged improved financial transparency and reaffirmed confidence in CEO Sir Lucian Grainge's strategy to sustain growth amid industry challenges like royalty debates and AI-generated deepfake music.